Unknown OBSERVATIONAL NCT05293483

The Impact of Covid-19 Hospital Care on the Prevalence of MDRO in Indonesia

The Impact of Hospital Care for COVID-19 on the Prevalence of Multidrug-resistant Microorganisms Among Patients Compared to Non-COVID-19 Hospital Care in Limited-resource Hospitals in Indonesia

Sponsor: British Society for Antimicrobial Chemotherapy

Conditions Antibiotic Resistant Infection COVID-19

Updated 4 times since 2022 Last updated: Mar 22, 2022 Started: Mar 7, 2022 Primary completion: Dec 7, 2022 Completion: Mar 7, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Antibiotic Resistant Infection and COVID-19, this trial is ongoing. The trial is conducted by British Society for Antimicrobial Chemotherapy and has accumulated 4 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Apr 2022 — Apr 2024 [monthly]

Recruiting

First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

British Society for Antimicrobial Chemotherapy
Erasmus Medical Center
Ngudi Waluyo Hospital
Saiful Anwar Hospital
University of Brawijaya

Data source: Erasmus Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Blitar, Indonesia
• Malang, Indonesia